Carmel Biosciences is a pharmaceutical company founded in 2016 that addresses critical needs in new drug and liquid reformulation for cardiovascular and metabolic therapies. The Carmel Biosciences team combines a deep understanding of lipid biochemistry and clinical expertise in the cardiovascular and metabolic space.
Mission Statement
Our mission is to provide winning therapeutic products which exhibit a high degree of safety and efficacy to the marketplace in a timely and cost efficient manner.
Strengths and Competitive Advantage
A corporate focus devoted to identification, evaluation and development of novel pharmaceutical formulations that can be developed expeditiously and at low cost
A world-class management and advisory team contributing their specialist experience in the fields of drug/product development, marketing and business development
The potential value from the portfolio of patent applications for treatment of cardiovascular diseases and metabolic disorders
Highly flexible and agile organization with our virtual strategy and process efficiencies
Opportunistic approach characterized by swift decision-making and ability to redirect research and business efforts at reduced time and cost